Addressing the growing cardiovascular risks faced by cancer patients and survivors.
Objectives
Early biomarker discovery
Identify and validate novel molecular, imaging and physiological biomarkers to detect early signs of cardiotoxicity before irreversible cardiac damage occurs.
AI-driven Clinical Decision Support
Deliver an interoperable, explainable AI-based CDSS to support clinicians in balancing effective cancer treatment with cardiovascular safety.
Personalised risk prediction
Develop AI-driven predictive models that integrate multimodal data (imaging, biomarkers, genomics, clinical data) to stratify individual cardiovascular risk.
Cardio-oncology care pathways
Establish harmonised, multidisciplinary care models that improve coordination between oncology and cardiology across Europe.
Real-time monitoring
Enable continuous, non-invasive monitoring of cardiac health using wearable technologies and digital health solutions to support timely clinical intervention.
Health, sustainability and regulatory integration
Assess cost-effectiveness, regulatory pathways and long-term sustainability to support real-world adoption of COMPASS solutions in healthcare systems.
